⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KURA News
Kura Oncology, Inc.
Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes
globenewswire.com
KURA
PM360 2026 Trailblazer Awards Winners Announced: Top Companies, Marketers, CEOs, Products, and Initiatives Honored at Gala, Sept. 29th
prnewswire.com
ABT
AZN
CYTK
ARDX
LLY
REGN
NVO
KURA
NOV
BMY
MRK
ARGX
BMRN
TAK
VRTX
GSK
APMD
GKOS
GEN
LAR
ABBV
INCY
GILD
MOD
IQV
PFE
ALGN
SCL
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
KURA
Caspian Therapeutics Appoints Manasi Jaiman, M.D., M.P.H., and Elizabeth Mily to Board of Directors
globenewswire.com
KURA
BMY
VRTX
TMO
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
globenewswire.com
KURA
Cyllene Therapeutics Appoints Seasoned Biotech Executive Dr Marc Grasso as Chief Financial Officer
globenewswire.com
KYMR
ALOT
KURA
Royalty Pharma announces $7.5 million gift to Blood Cancer United to expand Therapy Acceleration Program
globenewswire.com
RPRX
KURA
Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program
prnewswire.com
RPRX
KURA
Form 8-K
sec.gov
KURA
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes
globenewswire.com
KURA